URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jonathan Friedberg

Concepts (449)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
41
1999
436
9.710
Why?
Lymphoma, Non-Hodgkin
26
1999
113
9.380
Why?
Lymphoma, Large B-Cell, Diffuse
20
1999
80
8.450
Why?
Lymphoma, Follicular
18
1999
61
7.880
Why?
Antibodies, Monoclonal
31
2002
748
7.110
Why?
Antineoplastic Agents
26
2000
628
6.320
Why?
Antibodies, Monoclonal, Murine-Derived
35
2002
132
6.180
Why?
Hodgkin Disease
15
2002
156
4.070
Why?
Lymphoma, B-Cell
11
1999
66
4.040
Why?
Nitrogen Mustard Compounds
10
2007
20
3.640
Why?
Lymphoma, Mantle-Cell
6
2007
21
2.990
Why?
Lymphoma
8
2003
163
2.700
Why?
Drug Resistance, Neoplasm
10
2005
56
2.510
Why?
Radioimmunotherapy
7
2004
14
2.260
Why?
Treatment Outcome
31
1999
2671
2.250
Why?
Salvage Therapy
9
2007
62
2.230
Why?
Humans
110
1981
37165
2.230
Why?
Combined Modality Therapy
16
1999
491
2.190
Why?
Hematopoietic Stem Cell Transplantation
10
1999
133
2.020
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
4
2004
132
1.800
Why?
Neoplasms, Second Primary
6
1999
125
1.800
Why?
Boronic Acids
6
2007
30
1.790
Why?
Neoplasm Recurrence, Local
8
2001
295
1.790
Why?
Pyrazines
6
2007
34
1.780
Why?
Protein Kinase Inhibitors
3
2009
97
1.650
Why?
Middle Aged
49
1981
10013
1.610
Why?
Clinical Trials as Topic
14
2004
685
1.550
Why?
Oxazines
2
2009
30
1.540
Why?
Pyridines
3
2009
85
1.520
Why?
Adult
46
1981
11572
1.470
Why?
Immunotherapy
5
2000
88
1.460
Why?
Stem Cell Transplantation
8
2006
115
1.450
Why?
Intracellular Signaling Peptides and Proteins
2
2009
141
1.390
Why?
Protein-Tyrosine Kinases
2
2009
180
1.380
Why?
Survival Analysis
14
1998
589
1.320
Why?
Bone Marrow Transplantation
7
1999
201
1.310
Why?
Burkitt Lymphoma
2
2008
53
1.300
Why?
Survival Rate
15
1999
619
1.250
Why?
Transplantation, Autologous
13
1999
151
1.230
Why?
Aged
33
1981
7392
1.230
Why?
Doxorubicin
7
2003
105
1.170
Why?
Male
48
1993
20139
1.170
Why?
Recurrence
15
1998
697
1.160
Why?
Female
49
1981
20222
1.150
Why?
Deoxycytidine
4
2003
28
1.060
Why?
Medical Oncology
3
2008
49
1.040
Why?
Antigens, CD20
5
2003
27
1.040
Why?
Vidarabine
4
2004
28
0.980
Why?
Amifostine
2
2004
28
0.900
Why?
Neoplasm Staging
9
2003
354
0.870
Why?
Disease-Free Survival
11
2000
204
0.850
Why?
Protease Inhibitors
3
2007
42
0.850
Why?
Precursor Cells, B-Lymphoid
1
2012
7
0.840
Why?
Cytoprotection
2
2004
40
0.790
Why?
Antibiotics, Antineoplastic
1
2011
49
0.780
Why?
Histone Deacetylase Inhibitors
4
2010
27
0.780
Why?
Cyclophosphamide
8
1999
177
0.770
Why?
Immunologic Factors
4
2006
72
0.770
Why?
Heart Neoplasms
1
2009
22
0.710
Why?
Prognosis
9
1999
1078
0.710
Why?
Toll-Like Receptor 9
1
2009
12
0.700
Why?
B-Lymphocytes
5
2002
479
0.690
Why?
Heart Atria
1
2009
63
0.690
Why?
Follow-Up Studies
12
2001
1889
0.680
Why?
Neoplasm Proteins
2
2009
190
0.670
Why?
Gene Expression Profiling
1
2011
304
0.670
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
21
0.670
Why?
Agammaglobulinemia
1
2008
15
0.660
Why?
Oligodeoxyribonucleotides
2
2004
141
0.650
Why?
Cell Differentiation
2
2006
1127
0.630
Why?
Esophageal Neoplasms
1
2009
133
0.620
Why?
B-Lymphocyte Subsets
1
2008
68
0.610
Why?
Tomography, Emission-Computed
2
2003
32
0.590
Why?
Receptors, Tumor Necrosis Factor
1
2008
146
0.590
Why?
Oligopeptides
3
2010
91
0.570
Why?
Lymphocyte Depletion
2
2002
64
0.560
Why?
Drug Resistance
2
2005
100
0.540
Why?
Immunoglobulin G
1
2008
494
0.540
Why?
Aged, 80 and over
11
2002
2588
0.530
Why?
Cohort Studies
6
1999
984
0.510
Why?
Cell Transformation, Neoplastic
2
1999
138
0.500
Why?
Whole-Body Irradiation
2
2001
87
0.500
Why?
Eosinophilia
2
1993
33
0.500
Why?
Clozapine
2
1993
33
0.500
Why?
Antibodies, Neoplasm
3
2008
41
0.490
Why?
Gallium
1
2004
5
0.490
Why?
Immunoconjugates
1
2004
11
0.490
Why?
Practice Guidelines as Topic
3
2010
319
0.490
Why?
Interferon-beta
1
2004
63
0.480
Why?
Interferon-alpha
1
2004
85
0.480
Why?
Myelodysplastic Syndromes
2
1999
132
0.460
Why?
Tumor Necrosis Factor-alpha
1
2008
694
0.460
Why?
Risk Factors
11
1993
2331
0.440
Why?
Vincristine
5
2004
61
0.420
Why?
Pleural Neoplasms
1
2001
16
0.410
Why?
Randomized Controlled Trials as Topic
3
2006
415
0.410
Why?
Tympanoplasty
1
2001
2
0.410
Why?
Mesothelioma
1
2001
28
0.400
Why?
Adenoidectomy
1
2001
11
0.400
Why?
Tonsillectomy
1
2001
15
0.400
Why?
Pneumonia
1
2003
192
0.400
Why?
Interleukin-2
1
2002
203
0.390
Why?
Prednisone
5
2004
182
0.390
Why?
Neoplasms
2
2005
743
0.390
Why?
Lymphoma, B-Cell, Marginal Zone
3
2005
10
0.390
Why?
Guideline Adherence
2
2010
87
0.380
Why?
Thalidomide
2
2010
14
0.380
Why?
Trans-Activators
1
2004
366
0.380
Why?
Photochemotherapy
1
2001
112
0.370
Why?
Drug Synergism
5
2009
163
0.370
Why?
United States
9
2004
2847
0.370
Why?
Proteasome Endopeptidase Complex
2
2008
70
0.370
Why?
Cytarabine
3
2004
93
0.360
Why?
Somatostatin
1
1999
79
0.350
Why?
Drug Administration Schedule
4
2002
374
0.350
Why?
Vinblastine
3
2003
27
0.350
Why?
Antibodies, Monoclonal, Humanized
2
2008
94
0.340
Why?
Sarcoma
1
1999
64
0.340
Why?
Vitamin D
2
2009
71
0.340
Why?
Otitis Media
1
2001
131
0.330
Why?
Ultraviolet Rays
2
2009
197
0.330
Why?
Signal Transduction
6
2005
1629
0.330
Why?
DNA-Binding Proteins
1
2004
691
0.330
Why?
Incidence
6
1993
682
0.330
Why?
Melphalan
2
2004
28
0.320
Why?
Neoplasms, Radiation-Induced
2
2008
80
0.320
Why?
Carmustine
2
2004
37
0.320
Why?
Etoposide
2
2004
83
0.320
Why?
Antidepressive Agents
1
1998
93
0.300
Why?
Depressive Disorder
2
1993
326
0.290
Why?
T-Lymphocytes
3
2002
564
0.290
Why?
Dose-Response Relationship, Drug
4
1999
1142
0.280
Why?
Remission Induction
5
2001
165
0.270
Why?
Retrospective Studies
6
1994
2302
0.270
Why?
Colitis
1
1995
26
0.270
Why?
Child
8
1981
4342
0.260
Why?
Antineoplastic Agents, Alkylating
3
1999
44
0.260
Why?
Apoptosis
4
2005
855
0.260
Why?
Polymerase Chain Reaction
3
1999
597
0.260
Why?
Branchial Region
1
1993
4
0.240
Why?
Diagnostic Imaging
2
2010
86
0.240
Why?
Antibody-Dependent Cell Cytotoxicity
2
2002
28
0.240
Why?
Registries
2
2008
218
0.240
Why?
Bronchi
1
1994
86
0.240
Why?
Hydroxamic Acids
2
2010
20
0.240
Why?
Kaplan-Meier Estimate
2
2011
207
0.240
Why?
Trachea
1
1994
70
0.240
Why?
Foreign Bodies
1
1994
49
0.230
Why?
Antipsychotic Agents
1
1995
116
0.230
Why?
Extracellular Signal-Regulated MAP Kinases
2
2010
44
0.230
Why?
Psychotic Disorders
1
1993
68
0.230
Why?
Young Adult
4
2009
1084
0.230
Why?
Flow Cytometry
2
2004
603
0.230
Why?
Esophagus
1
1994
119
0.230
Why?
Hospitals, County
1
1992
1
0.220
Why?
Hospitals, General
1
1992
17
0.220
Why?
Age Factors
3
2001
1152
0.220
Why?
Cancer Vaccines
2
2007
32
0.220
Why?
Immunophenotyping
3
2002
126
0.220
Why?
Adolescent
8
1981
5044
0.220
Why?
Germinal Center
1
2012
17
0.210
Why?
Graft vs Host Disease
2
2002
95
0.210
Why?
Mitoxantrone
2
2004
20
0.210
Why?
Proto-Oncogene Proteins c-bcl-2
2
2009
116
0.210
Why?
Positron-Emission Tomography
2
2008
38
0.210
Why?
Pyrroles
1
2012
21
0.210
Why?
JNK Mitogen-Activated Protein Kinases
2
2009
106
0.210
Why?
Tumor Microenvironment
1
2011
13
0.210
Why?
Cell Separation
2
2002
230
0.210
Why?
Pneumocystis jirovecii
1
2011
5
0.210
Why?
Postoperative Complications
2
2001
764
0.210
Why?
Central Nervous System Neoplasms
1
2011
21
0.200
Why?
Molecular Targeted Therapy
1
2011
20
0.200
Why?
Interleukin-10
1
2012
100
0.200
Why?
Methylprednisolone
1
2011
46
0.200
Why?
Gastrointestinal Tract
1
2011
26
0.200
Why?
Hispanic Americans
1
2012
105
0.200
Why?
Referral and Consultation
2
1994
207
0.200
Why?
Databases, Factual
1
2012
159
0.200
Why?
Pancytopenia
1
2010
14
0.200
Why?
Maximum Tolerated Dose
1
2010
18
0.200
Why?
Disease Progression
2
2003
533
0.200
Why?
Mucositis
1
2010
14
0.200
Why?
Radiology
1
2011
29
0.190
Why?
Patient Selection
2
2007
223
0.190
Why?
Transplantation Conditioning
1
2010
36
0.190
Why?
Infant
5
1981
2320
0.190
Why?
Acute Disease
2
1993
591
0.190
Why?
Arabinonucleosides
1
2010
2
0.190
Why?
Waldenstrom Macroglobulinemia
1
2010
6
0.190
Why?
Immunoglobulin kappa-Chains
1
2010
30
0.190
Why?
Healthcare Disparities
1
2012
78
0.190
Why?
Child, Preschool
6
1981
2737
0.190
Why?
Genes, Immunoglobulin
1
2010
39
0.190
Why?
Adenine Nucleotides
1
2010
39
0.190
Why?
Immunoglobulin Heavy Chains
1
2010
47
0.190
Why?
Transplantation, Homologous
2
2002
280
0.180
Why?
Pneumonia, Pneumocystis
1
2011
121
0.180
Why?
European Continental Ancestry Group
1
2012
238
0.180
Why?
Diarrhea
1
2009
65
0.180
Why?
Hematologic Diseases
1
2009
40
0.180
Why?
Glucocorticoids
1
2011
168
0.180
Why?
MAP Kinase Kinase Kinases
1
2010
47
0.180
Why?
Esophagogastric Junction
1
2009
31
0.180
Why?
Chemokine CXCL10
1
2009
24
0.180
Why?
Endoscopy, Gastrointestinal
1
2009
28
0.180
Why?
Benzopyrans
1
2009
7
0.180
Why?
Comorbidity
2
2005
377
0.180
Why?
African Americans
1
2012
230
0.180
Why?
Drug Therapy, Combination
2
1999
397
0.180
Why?
Platinum Compounds
1
2009
7
0.180
Why?
Vitamin D Deficiency
1
2009
36
0.170
Why?
Multiple Myeloma
1
2010
75
0.170
Why?
Nitriles
1
2009
39
0.170
Why?
Fatal Outcome
1
2009
109
0.170
Why?
Atrial Fibrillation
1
2010
112
0.170
Why?
Forecasting
1
2010
188
0.170
Why?
Antigens, CD
2
2002
254
0.170
Why?
Protein Kinase C
1
2011
259
0.170
Why?
Predictive Value of Tests
3
2003
609
0.170
Why?
Radiotherapy, Adjuvant
1
2009
74
0.170
Why?
Chemotherapy, Adjuvant
1
2009
88
0.170
Why?
Daunorubicin
1
2008
25
0.170
Why?
Research Personnel
1
2008
17
0.170
Why?
Phosphatidylinositol 3-Kinases
1
2010
164
0.170
Why?
Databases as Topic
1
2008
36
0.170
Why?
Cancer Care Facilities
1
2008
12
0.170
Why?
SEER Program
1
2009
55
0.170
Why?
Time Factors
4
2004
3234
0.170
Why?
Endoplasmic Reticulum
1
2009
96
0.160
Why?
Echocardiography
1
2009
217
0.160
Why?
Yttrium Radioisotopes
1
2008
1
0.160
Why?
Bone Marrow Purging
1
2008
4
0.160
Why?
Immunoglobulin Class Switching
1
2008
19
0.160
Why?
Gene Expression Regulation, Neoplastic
1
2011
266
0.160
Why?
Drugs, Investigational
1
2008
8
0.160
Why?
Italy
1
2008
23
0.160
Why?
Graft Survival
3
2002
151
0.160
Why?
Sinusitis
1
2008
24
0.160
Why?
Breast Neoplasms
2
2002
666
0.160
Why?
Myeloid Cells
1
2008
14
0.160
Why?
Chemokine CCL2
1
2009
128
0.160
Why?
Cytogenetics
1
2008
15
0.160
Why?
National Cancer Institute (U.S.)
1
2008
12
0.160
Why?
Antibody Formation
1
2009
178
0.160
Why?
Immunoglobulins, Intravenous
1
2008
37
0.160
Why?
Drug Monitoring
1
2008
41
0.160
Why?
Genes, myc
1
2008
28
0.160
Why?
Biopsy, Fine-Needle
1
2008
20
0.160
Why?
Cell Line, Tumor
4
2009
576
0.160
Why?
CD4 Lymphocyte Count
1
2008
160
0.160
Why?
HIV Seropositivity
1
2008
36
0.160
Why?
Epitopes
1
2008
208
0.160
Why?
Pyrimidines
1
2008
66
0.160
Why?
Bleomycin
2
2003
47
0.150
Why?
Radiotherapy Dosage
1
2008
202
0.150
Why?
Health Status Indicators
1
2008
112
0.150
Why?
Piperazines
1
2008
76
0.150
Why?
Drug Delivery Systems
1
2008
61
0.150
Why?
Immunocompromised Host
1
2008
85
0.150
Why?
Gene Rearrangement
2
2002
39
0.150
Why?
Data Collection
1
2008
231
0.150
Why?
In Situ Hybridization, Fluorescence
1
2008
114
0.150
Why?
Leukemia, Myeloid
1
2008
121
0.150
Why?
Introns
1
2008
112
0.150
Why?
Interferon-gamma
1
2009
341
0.150
Why?
Immunologic Memory
1
2008
129
0.150
Why?
Tumor Markers, Biological
1
2009
240
0.150
Why?
Time
1
2006
47
0.150
Why?
Mice, Nude
3
2010
179
0.140
Why?
Liver
1
2011
884
0.140
Why?
Leukemia, Myeloid, Acute
1
2008
183
0.140
Why?
Radiotherapy
1
2008
198
0.140
Why?
Psittacosis
1
2005
2
0.140
Why?
Chlamydophila psittaci
1
2005
3
0.140
Why?
Hypertension
1
2009
307
0.140
Why?
Proteins
1
2009
470
0.140
Why?
Eye Neoplasms
1
2005
21
0.140
Why?
Molecular Biology
1
2006
45
0.140
Why?
Immunohistochemistry
1
2009
1082
0.130
Why?
Brain Neoplasms
1
2008
282
0.130
Why?
Complement C1q
1
2005
8
0.130
Why?
Cell Division
1
2008
773
0.130
Why?
Hospitalization
2
1993
385
0.130
Why?
Promoter Regions, Genetic
1
2008
558
0.120
Why?
STAT1 Transcription Factor
1
2004
21
0.120
Why?
Neoplastic Cells, Circulating
1
2003
7
0.120
Why?
Iodine Radioisotopes
1
2004
104
0.120
Why?
Blood Component Removal
1
2003
11
0.120
Why?
Risk
2
2001
355
0.120
Why?
Cause of Death
2
2001
158
0.120
Why?
Prospective Studies
4
2002
1696
0.120
Why?
Random Allocation
1
2004
253
0.120
Why?
Magnetic Resonance Imaging
1
2009
1019
0.110
Why?
Infusions, Intravenous
1
2003
143
0.110
Why?
Fluorine Radioisotopes
1
2003
8
0.110
Why?
Administration, Oral
1
2004
314
0.110
Why?
Proportional Hazards Models
2
2001
426
0.110
Why?
Schizophrenia
2
1993
120
0.110
Why?
Fluorodeoxyglucose F18
1
2003
15
0.110
Why?
Radiopharmaceuticals
1
2003
49
0.110
Why?
Chromosomes, Human, Pair 18
1
2002
15
0.110
Why?
Chromosomes, Human, Pair 14
1
2002
17
0.110
Why?
Antigens, CD56
1
2002
15
0.110
Why?
Eosinophils
1
2002
46
0.110
Why?
Histocompatibility
1
2002
14
0.110
Why?
Lymphoma, T-Cell
1
2002
11
0.110
Why?
Breast Implants
1
2002
13
0.100
Why?
MAP Kinase Kinase 4
2
2011
27
0.100
Why?
Pneumonectomy
1
2001
14
0.100
Why?
Pleural Effusion
1
2001
30
0.100
Why?
Positive-Pressure Respiration
1
2001
27
0.100
Why?
Epidemiologic Methods
1
2001
58
0.100
Why?
Analysis of Variance
2
1998
749
0.100
Why?
Ontario
1
2001
12
0.100
Why?
Biological Markers
1
2004
564
0.100
Why?
Lymph Node Excision
1
2001
54
0.100
Why?
Laser Therapy
1
2001
63
0.100
Why?
Tongue Neoplasms
1
1981
5
0.100
Why?
Thyroglossal Cyst
1
1981
7
0.100
Why?
Radiation-Sensitizing Agents
1
2001
74
0.100
Why?
Xenograft Model Antitumor Assays
2
2010
46
0.100
Why?
Choristoma
1
1981
23
0.100
Why?
Thyroid Gland
1
1981
54
0.100
Why?
Risk Assessment
2
1999
875
0.100
Why?
Gene Expression
1
2004
764
0.100
Why?
Reoperation
1
2001
190
0.090
Why?
Sensitivity and Specificity
1
2004
914
0.090
Why?
Octreotide
1
1999
5
0.090
Why?
Indium Radioisotopes
1
1999
4
0.090
Why?
Abdominal Neoplasms
1
1999
17
0.090
Why?
CD8-Positive T-Lymphocytes
1
2002
229
0.090
Why?
Sarcoma, Synovial
1
1999
7
0.090
Why?
Thigh
1
1999
24
0.090
Why?
Chondrosarcoma
1
1999
15
0.090
Why?
Hematopoietic Stem Cells
1
2002
200
0.090
Why?
Karyotyping
1
1999
112
0.090
Why?
Medical Records
2
2008
140
0.090
Why?
Tomography, Emission-Computed, Single-Photon
1
1999
71
0.090
Why?
Histones
2
2011
173
0.090
Why?
Liver Neoplasms
1
1999
155
0.080
Why?
Enzyme Activation
2
2009
611
0.080
Why?
Bone Neoplasms
1
1999
208
0.080
Why?
Enzyme Inhibitors
2
2009
441
0.070
Why?
Statistics, Nonparametric
1
1998
269
0.070
Why?
Lung Neoplasms
1
1999
435
0.070
Why?
Mice
3
2010
6206
0.060
Why?
Reproducibility of Results
2
2008
903
0.060
Why?
Logistic Models
2
2004
626
0.060
Why?
Respiratory Sounds
1
1994
19
0.060
Why?
Bronchoscopy
1
1994
30
0.060
Why?
Esophagoscopy
1
1994
57
0.060
Why?
Posture
1
1994
112
0.060
Why?
Patient Admission
1
1994
84
0.060
Why?
Leukocyte Count
1
1993
162
0.060
Why?
Infant, Newborn
2
1981
1836
0.060
Why?
Syndrome
1
1993
209
0.060
Why?
Catheterization
1
1994
124
0.060
Why?
Wisconsin
1
1992
8
0.060
Why?
Length of Stay
1
1994
295
0.050
Why?
Neoplasm Grading
1
2012
9
0.050
Why?
Receptors, Antigen, B-Cell
1
2012
20
0.050
Why?
Lung
1
1999
1148
0.050
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2012
5
0.050
Why?
Watchful Waiting
1
2012
2
0.050
Why?
Anthracyclines
1
2012
17
0.050
Why?
bcl-2-Associated X Protein
1
2012
55
0.050
Why?
Apoptosis Regulatory Proteins
1
2012
27
0.050
Why?
Drug Evaluation
1
2011
99
0.050
Why?
Cell Cycle Checkpoints
1
2011
4
0.050
Why?
Oncogene Protein v-akt
1
2011
5
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Sex Factors
1
1993
613
0.050
Why?
Histone Deacetylases
1
2012
72
0.050
Why?
History, 20th Century
1
1992
245
0.050
Why?
Protein Kinases
1
2012
124
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2012
133
0.050
Why?
Superoxide Dismutase
1
2011
75
0.050
Why?
Leukopenia
1
2010
26
0.050
Why?
Population Surveillance
1
2012
144
0.050
Why?
Diagnosis, Differential
1
1994
889
0.050
Why?
Caspases
1
2011
105
0.050
Why?
Reed-Sternberg Cells
1
2010
5
0.050
Why?
Microdissection
1
2010
8
0.050
Why?
Paraffin Embedding
1
2010
14
0.050
Why?
Formaldehyde
1
2010
24
0.050
Why?
Tissue Fixation
1
2010
20
0.050
Why?
Chymotrypsin
1
2010
9
0.050
Why?
Disease Management
1
2010
31
0.050
Why?
Multicenter Studies as Topic
1
2010
127
0.050
Why?
Anemia
1
2010
78
0.050
Why?
Benzenesulfonates
1
2010
8
0.050
Why?
DNA, Neoplasm
1
2010
129
0.050
Why?
Benzamides
1
2010
18
0.050
Why?
Calcifediol
1
2009
6
0.050
Why?
Dihydroxycholecalciferols
1
2009
9
0.050
Why?
Clone Cells
1
2010
188
0.050
Why?
Nutrition Policy
1
2009
11
0.050
Why?
Societies, Medical
1
2011
142
0.050
Why?
Animals
3
2010
16416
0.040
Why?
Seasons
1
2009
91
0.040
Why?
Dietary Supplements
1
2009
46
0.040
Why?
Proto-Oncogene Proteins
1
2012
301
0.040
Why?
Nausea
1
2010
155
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
DNA Damage
1
2010
164
0.040
Why?
Cladribine
1
2008
7
0.040
Why?
Blast Crisis
1
2008
19
0.040
Why?
Physician's Practice Patterns
1
2012
268
0.040
Why?
Protein Binding
1
2012
867
0.040
Why?
Immunity, Cellular
1
2009
135
0.040
Why?
Cell Cycle
1
2010
253
0.040
Why?
Granulocyte Colony-Stimulating Factor
1
2008
45
0.040
Why?
Observer Variation
1
2008
146
0.040
Why?
Phosphorylation
1
2011
839
0.040
Why?
Multivariate Analysis
1
2010
548
0.040
Why?
Case-Control Studies
1
2010
624
0.040
Why?
Evidence-Based Medicine
1
2009
210
0.040
Why?
Membrane Proteins
1
2012
560
0.040
Why?
Antibodies, Anti-Idiotypic
1
2007
57
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
543
0.040
Why?
Blotting, Western
1
2010
672
0.040
Why?
Tomography, X-Ray Computed
1
2012
785
0.040
Why?
Dacarbazine
1
2007
21
0.040
Why?
Polyethylene Glycols
1
2007
57
0.040
Why?
Severity of Illness Index
1
2011
943
0.040
Why?
Bone Marrow
1
2008
292
0.040
Why?
Mitochondria
1
2010
346
0.040
Why?
Neutropenia
1
2007
70
0.040
Why?
Thrombocytopenia
1
2007
77
0.040
Why?
Transfection
1
2010
887
0.040
Why?
NF-kappa B
1
2010
434
0.030
Why?
DNA, Bacterial
1
2005
169
0.030
Why?
Prednisolone
1
2004
25
0.030
Why?
Radiation-Protective Agents
1
2004
41
0.030
Why?
Cytokines
1
2007
575
0.030
Why?
Chi-Square Distribution
1
2004
347
0.030
Why?
Bone Marrow Cells
1
2004
222
0.030
Why?
Radiotherapy, High-Energy
1
2002
24
0.030
Why?
Silicone Gels
1
2002
10
0.030
Why?
Dose-Response Relationship, Radiation
1
2002
216
0.030
Why?
Hematopoietic Stem Cell Mobilization
1
2002
15
0.030
Why?
Microspheres
1
2002
56
0.030
Why?
Tissue Donors
1
2002
70
0.030
Why?
Antigens, Differentiation, B-Lymphocyte
1
2002
51
0.030
Why?
Hyoid Bone
1
1981
5
0.020
Why?
Mediastinal Neoplasms
1
1981
21
0.020
Why?
Survivors
1
2002
118
0.020
Why?
Pilot Projects
1
2002
446
0.020
Why?

Visualizations


Friedberg's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department